K992948 · General Electric Medical Systems Information Techn · DQK · Nov 29, 1999 · Cardiovascular
Device Facts
Record ID
K992948
Device Name
MAC-LAB SYSTEM
Applicant
General Electric Medical Systems Information Techn
Product Code
DQK · Cardiovascular
Decision Date
Nov 29, 1999
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 870.1425
Device Class
Class 2
Attributes
Pediatric
Intended Use
The MAC-LAB System is intended for use under the direct supervision of a licensed healthcare practitioner to monitor and/or calculate and/or record cardiovascular data from patients as they undergo cardiac catheterization. Cardiovascular data may be manually entered or acquired via an interfaced GE Marquette TRAM modules (k921669), MUSE cardiovascular system and other interfaced information systems. Data includes: ECG waveforms, heart rate, pulse oximetry (SpO-), respiration rate, valve gradients and areas, cardiac output, hemodynamic measurements, invasive and noninvasive blood pressure, procedural information, and optional intracardiac electrocardiogram (IECG). Applicable to pediatric/adult patients requiring cardiac/circulatory system catheterization Intended for use in catheterization and related cardiovascular specialty labs
Device Story
MAC-LAB System is a programmable diagnostic computer for cardiac catheterization labs; operates under physician supervision. Inputs include ECG waveforms, heart rate, pulse oximetry, respiration rate, hemodynamic measurements, and intracardiac electrocardiogram (IECG) signals via TRAM modules in a Remote Acquisition Unit (RAU). System processes, displays, trends, stores, and prints cardiovascular data; supports transmission to networked hospital information systems. Provides real-time monitoring and calculations (e.g., valve gradients, cardiac output) to assist clinicians in procedural decision-making during catheterization. Benefits include integrated data management and visualization of physiological parameters during cardiac interventions.
Clinical Evidence
Bench testing only. No clinical data provided. Safety and effectiveness were established through requirements specification review, code inspections, software and hardware testing, safety testing, environmental testing, and final validation.
Technological Characteristics
System includes Remote Acquisition Unit (RAU) with TRAM modules, computer processors, high-resolution display monitors, power supply, thermal printer, and keyboard. Uses electronic amplifiers for signal processing. Connectivity includes networking to hospital information systems. Software-based diagnostic computer.
Indications for Use
Indicated for pediatric and adult patients undergoing cardiac or circulatory system catheterization in a cardiovascular specialty lab.
Regulatory Classification
Identification
A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs.
K061741 — MAC-LAB/CARDIOLAB /COMBOLAB/SPECIALSLAB SYSTEM · GE Healthcare · Sep 15, 2006
K130626 — MAC-LAB HEMODYNAMIC RECORDING SYSTEM; CARDIOLAB ELECTROPHYSIOLOGY RECORDING SYSTEM; COMBOLAB HEMODYNAMIC AND ELECTROPHYS · Ge Medical Systems Information Technologies, Inc. · May 1, 2013
K032577 — MODIFICATION TO: MAC-LAB/CARDIOLAB EP/COMBOLAB SYSTEM · Ge Medical Systems Information Technologies · Oct 10, 2003
K021906 — QUINTON Q-CATH, MODEL 000460 · Quinton, Inc. · Sep 4, 2002
K213972 — Mac-Lab Recording Systems AltiX, CardioLab Recording Systems AltiX, ComboLab Recording Systems AltiX, MLCL Client Software AltiX · Ge Healthcare Information Technologies, Inc. · Feb 17, 2022
Submission Summary (Full Text)
{0}------------------------------------------------
Devic
Cor
GE Marquette Medical Systems, Inc.
## Section 2: 510(k) Summary of Safety and Effectiveness
| | Date: August 28, 1999 |
|-----------------------|---------------------------------------------------------------------------------------------------------------------------------------------|
| Submitter: | GE Marquette Medical Systems<br>100 Marquette Drive<br>Jupiter, FL USA |
| Contact Person: | Maria Vitug Fouts<br>Sr. Regulatory Compliance Specialist<br>GE Marquette Medical Systems<br>Phone: (410) 573-6294<br>Fax: (410) 897 - 6294 |
| Trade Name: | MAC-LAB System |
| Common/Usual Name: | MAC-LAB, MAC-LAB System EX |
| Classification Names: | 21 CFR 870.1425 Programmable Diagnostic Computer |
| Predicate Devices: | MAC-LAB Cardiac System,<br>k895801, SE date: 04 April 1990 |
MAC-LAB Electrophysiology (IECG)Option, K935394, SE date: 20 October 1994
- Device Description: The MAC-LAB Systems ioin together the TRAM module which is housed in a Remote Acquisition Unit (RAU) with computer processors, software, high resolution display monitors, power supply, thermal printer and a keyboard. Data acquisition modules, depending upon application, are inserted into the RAU and then digital data is transmitted, via cable, to the computers for An optional IECG module (K935394) processing. enables electrophysiological investigations of the heart to be performed. The IECG module consists of electronic amplifiers and other signal processing devices. An IECG cable connects an intracardiac catheter (not covered by this submission) to the IECG system.
- The MAC-LAB Systems are intended for use under the direct supervision of Intended Use: a licensed healthcare practitioner. The device is intended to monitor and/or calculate and/or record cardiovascular data from patients as they undergo catheterization of the heart and circulatory system. Data includes: ECG waveforms, heart rate, pulse oximetry, respiration rate, valve gradients and areas, cardiac output, hemodynamic measurements, invasive and noninvasive blood pressure, procedural information, and optional intracardiac electrocardiogram (IECG). This information can be displayed, trended, stored, printed and/or transmitted to other networked hospital information systems.
Applicable to pediatric/adult patients requiring cardiac/circulatory system catheterization
Intended for use in catheterization and related cardiovascular specialty labs.
{1}------------------------------------------------
GE Marquette Medical Systems, Inc.
## Section 2: 510(k) Summary of Safety and Effectiveness, continued
The proposed MAC-LAB Cardiac Catheterization Laboratory System Technology: employs the same functional technology as the predicate devices.
- Test Summary: The MAC-LAB complies with the voluntary standards as detailed in Section 9 of this submission. The following quality assurance measures were applied to the development of the MAC-LAB System:
- . Requirements specification review
- Code inspections .
- . Software and hardware testing
- . Safety testing
- Environmental testing .
- Final validation .
- Conclusion: The results of these measurements demonstrated that the MAC-LAB system is as safe, as effective, and performs as well as the predicate devices.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo is a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle or other bird with its wings spread.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
NOV 2 9 1999
Ms. Maria Vitug Fouts Senior Requlatory Compliance Specialist GE Marquette Medical Systems A GE Medical Systems Company 200 Harry S. Truman Parkway, Suite 220 Annapolis, Maryland 21401
Re: K992948 Trade Name: MAC-LAB System Version 18A Requlatory Class: 2 Product Code: 74-DQK Dated: August 28, 1999 Received: August 31, 1999
Dear Ms. Fouts:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual reqistration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act
{3}------------------------------------------------
Page 2 - Ms. Maria Vitug Fouts
for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4645. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at Also, please note the regulation entitled, (301) 594-4639. "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Dank Miller
lia M. Witten, Ph.D., M.D. Acting Director Division of Cardiovascular, Respiratory and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
K992948
510(k) Number (if known):
MAC-LAB System Device Name:
Indications For Use:
The MAC-LAB System is intended for use under the direct supervision of a licensed healthcare practitioner to monitor and/or calculate and/or record cardiovascular data from patients as they undergo cardiac catheterization. Cardiovascular data may be manually entered or acquired via an interfaced GE Marquette TRAM modules (k921669), MUSE cardiovascular system and other interfaced information systems. Data includes: ECG waveforms, heart rate, pulse oximetry (SpO-), respiration rate, valve gradients and areas, cardiac output, hemodynamic measurements, invasive and noninvasive blood pressure, procedural information, and optional intracardiac electrocardiogram (IECG).
Applicable to pediatric/adult patients requiring cardiac/circulatory system catheterization
Intended for use in catheterization and related cardiovascular specialty labs
Note: Catheterization devices are not provided or offered for use with the MAC-LAB system.
*To be assigned by FDA upon receipt of 510(k) submission
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division 3)
Division of Cardiovascular, Respiratory,
and Neurological Devices,
510(k) Number K992948
Prescription Use
(Per 21 CFR 801.109)
OR Over-The-Counter Use
(Optional Format 1-2-96)
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.